“Metal-on-metal” hip implant concerns on the riseThe New York Times published an article on concerns related to “metal-on-metal” hip implants. Read the article at http://www.nytimes.com/2010/03/04/health/04metalhip.html?partner=rss&emc=rss.
Coffee drinking and arrhythmiasCoffee drinkers are less likely to be hospitalized for cardiac arrhythmias, according to a report presented at the American Heart Association’s 50th Annual Conference…
New guidelines for treatment of malariaThe World Health Organization has released new guidelines for malaria treatment to counter the misuse of anti-malarial drugs. Access the guidelines at http://www.who.int/malaria/en/.
Early imaging reduces length of stayAccording to the study “Patients Imaged Early During Admission Demonstrate Reduced Length of Hospital Stay: A Retrospective Cohort Study of Patients Undergoing Cross-Sectional Imaging,”…
Nearly half of nurses plan career changeA 2010 survey of registered nurses from AMN healthcare found that 44% of the 1,399 nurses who completed the survey plan to make a…
Cognitive behaviorial therapyA study of 701 adults with subacute or chronic back pain found that cognitive behavioral therapy reduced pain and disability compared to those who…
Counterfeit surgical meshOn March 11, the U.S. Food and Drug Administration issued a warning about counterfeit surgical mesh being distributed under C. R. Bard/Davol brand name.…
FDA approves new implanted hearing systemOn March 17, the U.S. Food and Drug Administration announced the approval of the Esteem, an implanted hearing system for moderate to severe sensorineural…
USDA new safety requirements for beta-agonistsThe U.S. Food and Drug Administration has new safety requirements for long-acting beta-agonists used to treat asthma. Read the requirements at http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm200776.htm.,/p>
The US Food and Drug Administration has approved two drugsMorphine Sulfate Oral Solution, used to relieve moderate to severe pain in patients tolerant to opioids. liraglutide (Victoza), a once-daily injection for treating type…
Drug approval for breast cancerThe U.S. Food and Drug Administration has approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer…
March of Dimes releases new nursing education modulesThe March of Dimes has released three new nursing education modules: Diabetes in Pregnancy, 4th Edition; Genetic Issues for Perinatal Nurses, 3rd Edition; and…
“Metal-on-metal” hip implant concerns on the riseThe New York Times published an article on concerns related to “metal-on-metal” hip implants. Read the article at http://www.nytimes.com/2010/03/04/health/04metalhip.html?partner=rss&emc=rss.
Coffee drinking and arrhythmiasCoffee drinkers are less likely to be hospitalized for cardiac arrhythmias, according to a report presented at the American Heart Association’s 50th…
New guidelines for treatment of malariaThe World Health Organization has released new guidelines for malaria treatment to counter the misuse of anti-malarial drugs. Access the guidelines at…
Early imaging reduces length of stayAccording to the study “Patients Imaged Early During Admission Demonstrate Reduced Length of Hospital Stay: A Retrospective Cohort Study of Patients Undergoing…
Nearly half of nurses plan career changeA 2010 survey of registered nurses from AMN healthcare found that 44% of the 1,399 nurses who completed the survey plan to…
Cognitive behaviorial therapyA study of 701 adults with subacute or chronic back pain found that cognitive behavioral therapy reduced pain and disability compared to…
Counterfeit surgical meshOn March 11, the U.S. Food and Drug Administration issued a warning about counterfeit surgical mesh being distributed under C. R. Bard/Davol…
FDA approves new implanted hearing systemOn March 17, the U.S. Food and Drug Administration announced the approval of the Esteem, an implanted hearing system for moderate to…
USDA new safety requirements for beta-agonistsThe U.S. Food and Drug Administration has new safety requirements for long-acting beta-agonists used to treat asthma. Read the requirements at http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm200776.htm.,/p>
The US Food and Drug Administration has approved two drugsMorphine Sulfate Oral Solution, used to relieve moderate to severe pain in patients tolerant to opioids. liraglutide (Victoza), a once-daily injection for…
Drug approval for breast cancerThe U.S. Food and Drug Administration has approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced…
March of Dimes releases new nursing education modulesThe March of Dimes has released three new nursing education modules: Diabetes in Pregnancy, 4th Edition; Genetic Issues for Perinatal Nurses, 3rd…
